Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Comments Comments
  •  (1)
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

Intelence Now for Kids Ages 6 and Older

May/June 2012

The HIV drug Intelence (etravirine) received approval from the Food and Drug Administration (FDA) for use by children ages six to 18 weighing at least 35 pounds, who have previous anti-HIV treatment experience. This includes children whose virus has developed drug resistance to the same class of medications as Intelence (non-nucleoside reverse transcriptase inhibitors, or NNRTIs). Sustiva and Viramune are the NNRTIs previously available for pediatric use. A new scored 25 mg tablet of Intelence is now available for pediatrics.

For more information about the drug, go to www.positivelyaware.com/intelence

View Full Article


  
  • Email Email
  • Comments Comments
  •  (1)
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

Visit Positively Aware's website to find out more about the publication.
 
See Also
More on HIV Medications
More News and Research on Etravirine (Intelence)
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Reader Comments:

Comment by: dailyrx Thu., Jan. 3, 2013 at 11:43 am EST
According to http://www.rxwiki.com/intelence, the drug is meant to be used in combination with other meds. What other medications have been approved for children?
Reply to this comment


Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement